Mainz Biomed N.V. (MYNZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 06-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,344 | -11,024 | -26,296 | -21,112 | -14,813 |
| Depreciation Amortization | 500 | 497 | 866 | 662 | 458 |
| Accounts receivable | -100 | -65 | 16 | -86 | 59 |
| Other Working Capital | -113 | 661 | -65 | -300 | 1,383 |
| Other Operating Activity | 1,541 | 1,786 | 3,540 | 3,552 | 2,135 |
| Operating Cash Flow | $-6,516 | $-8,145 | $-21,939 | $-17,284 | $-10,778 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1 | -121 | -1,199 | -1,037 | -1,025 |
| Purchase Sale Intangibles | -450 | -300 | -700 | -600 | -500 |
| Other Investing Activity | -450 | -300 | -700 | -600 | -500 |
| Investing Cash Flow | $-451 | $-421 | $-1,899 | $-1,637 | $-1,525 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,970 | 10,120 | 10,120 | 5,060 |
| Debt Repayment | -600 | -788 | -1,100 | N/A | N/A |
| Common Stock Issued | 3,535 | 515 | 6,393 | 1,893 | 1,895 |
| Other Financing Activity | -259 | -146 | -1,186 | -1,252 | -762 |
| Financing Cash Flow | $2,676 | $2,551 | $14,227 | $10,761 | $6,193 |
| Exchange Rate Effect | -33 | -79 | -460 | 338 | -121 |
| Beginning Cash Position | 6,236 | 7,071 | 17,142 | 17,142 | 17,142 |
| End Cash Position | 1,911 | 978 | 7,071 | 9,320 | 10,911 |
| Net Cash Flow | $-4,325 | $-6,093 | $-10,071 | $-7,821 | $-6,231 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,516 | -8,145 | -21,939 | -17,284 | -10,778 |
| Capital Expenditure | -1 | -121 | -1,199 | -1,037 | -1,025 |
| Free Cash Flow | -6,517 | -8,265 | -23,138 | -18,321 | -11,803 |